Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

ClinicalTrials.gov ID: NCT07662135

Public ClinicalTrials.gov record NCT07662135. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 7, 2026, 1:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin (Eluminate-4)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron, compared with placebo in adults with type 2 diabetes mellitus (T2DM) and impaired renal function, who are or will be on a background of sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin 10 mg as per guideline directed medical therapy (GDMT) for chronic kidney disease (CKD). Additionally, participants are on other glucose-lowering medication(s).

Study identification

NCT ID
NCT07662135
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
900 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 5, 2026
Primary completion
Jul 12, 2028
Completion
Jul 12, 2028
Last update posted
Sep 1, 2026

2026 – 2028

United States locations

U.S. sites
33
U.S. states
19
U.S. cities
32
Facility City State ZIP Site status
Research Site Sun City Arizona 85373 Not yet recruiting
Research Site Surprise Arizona 85374 Not yet recruiting
Research Site Concord California 94520 Not yet recruiting
Research Site Sacramento California 95821 Recruiting
Research Site Victorville California 92392 Not yet recruiting
Research Site Fleming Island Florida 32003 Not yet recruiting
Research Site Lauderdale Lakes Florida 33313 Not yet recruiting
Research Site Leesburg Florida 34748 Not yet recruiting
Research Site Miami Lakes Florida 33016 Recruiting
Research Site Ocoee Florida 34761 Recruiting
Research Site Orlando Florida 32804 Not yet recruiting
Research Site Chicago Illinois 60640 Not yet recruiting
Research Site Braintree Massachusetts 02184 Not yet recruiting
Research Site New Bedford Massachusetts 02740 Not yet recruiting
Research Site Worcester Massachusetts 01604 Not yet recruiting
Research Site Saint Joseph Michigan 49085 Suspended
Research Site Saint Paul Minnesota 55117 Not yet recruiting
Research Site Kansas City Missouri 64112 Recruiting
Research Site Omaha Nebraska 68144 Not yet recruiting
Research Site Las Vegas Nevada 89119 Not yet recruiting
Research Site Albuquerque New Mexico 87102 Recruiting
Research Site The Bronx New York 10451 Not yet recruiting
Research Site Kinston North Carolina 28504 Not yet recruiting
Research Site Raleigh North Carolina 27609 Recruiting
Research Site Winston-Salem North Carolina 27103 Not yet recruiting
Research Site Cincinnati Ohio 45219 Not yet recruiting
Research Site East Providence Rhode Island 02914 Not yet recruiting
Research Site Gaffney South Carolina 29340 Recruiting
Research Site Greenville South Carolina 29605 Not yet recruiting
Research Site San Antonio Texas 78212 Suspended
Research Site San Antonio Texas 78257 Not yet recruiting
Research Site Ogden Utah 84405 Not yet recruiting
Research Site Arlington Virginia 22205 Suspended

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 153 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07662135, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 1, 2026 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07662135 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →